Although the serum-induced elevation of ROS in GSCs also caused a decrease in neurosphere formation in vitro and a reduced expression of stem cell markers such as CD133, this apparent differentiation did not reduce the ability of the glioma stem cells to form tumor in vivo. This evidence concerns the gene PROM1 and central nervous system cancer.